Viewing Study NCT02207504


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-03-09 @ 7:34 AM
Study NCT ID: NCT02207504
Status: COMPLETED
Last Update Posted: 2022-01-06
First Post: 2014-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module